Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02380963 · ClinicalTrials.gov registry record · NA

Effect of Soy Protein and Colorado Diet on Weight Loss and Maintenance

A NA study of Obesity and Overweight, sponsored by DuPont Nutrition and Health.

Completed
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT02380963 is a NA study of Obesity and Overweight that has completed, run by DuPont Nutrition and Health. The registered enrollment target is 72 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02380963, a NA study of Obesity and Overweight, has completed, sponsored by DuPont Nutrition and Health.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

Dietary protein is a key element of most effective weight loss regimens. This study will investigate the effects of consuming soy protein on body composition and cardiometabolic health within the context of an effective weight loss and maintenance program called the Colorado Diet.

Interventions

  • DIETARY_SUPPLEMENT Colorado Diet with soy protein foods.
  • BEHAVIORAL Colorado Diet with monetary payments

Study Locations (1)

Colorado

  • Anschutz Health and Wellness Center, University of Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2015-02
Est. Completion 2016-11
Phase NA

Sponsor

DuPont Nutrition and Health

5 total trials

What the Registry Record Tells You About NCT02380963

The ClinicalTrials.gov registry entry for NCT02380963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The listed sponsor is DuPont Nutrition and Health, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Colorado Diet with soy protein foods. is the first listed.

NCT02380963 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02380963 about?

NCT02380963 is a clinical study titled "Effect of Soy Protein and Colorado Diet on Weight Loss and Maintenance". Dietary protein is a key element of most effective weight loss regimens. This study will investigate the effects of consuming soy protein on body composition and cardiometabolic health within the context of an effective weight loss and maintenance program called the Colorado Diet.

What is the current status of trial NCT02380963?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2015-02. Estimated completion is 2016-11.

What conditions does trial NCT02380963 study?

This clinical trial studies the following conditions: Obesity, Overweight, Weight Loss.

What interventions are being tested in trial NCT02380963?

The interventions under investigation include: Colorado Diet with soy protein foods. (DIETARY_SUPPLEMENT), Colorado Diet with monetary payments (BEHAVIORAL).

Who is sponsoring clinical trial NCT02380963?

This trial is sponsored by DuPont Nutrition and Health, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02380963 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.